Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data BLOOMIA HOLDINGS, INC. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2026
Revenue
24.9
26.4
33.2
21.5
17.5
19.5
18.8
37.8
48.1
Cost of revenue
17.8
18
20.7
17.2
0.53
0
15.5
31.3
40.2
Gross profit
7.06
8.4
12.6
4.34
2.86
3.23
3.3
6.51
7.89
Selling, general and administrative
3.52
13.2
11.6
Selling and marketing
0
0.2
General and administrative
4.11
4.05
4.63
3.38
4
5.06
2.44
3.32
Operating expenses
9.14
9.31
10.7
10.4
7.7
8.02
2.44
3.52
Operating income
-2.08
-0.91
1.83
-6.11
-4.84
-4.79
-2.44
-3.52
-6.72
-16.9
Interest income
0.15
0.52
Other non-operating income
-0.02
-0
0.05
0.11
0.07
0
0.06
-0.03
Pre-tax income
-2.1
-0.91
1.88
-6
0
0.27
-2.29
-3
-9.23
-14
Income tax
-0.81
-0.27
0.48
-0.42
-0.19
0.04
0.01
0.02
-2.33
-0.58
Income from continuing operations
-2.29
-3.02
-6.9
-13.4
Net income to minority interests
-0.93
-2.2
Net income
-1.29
-0.64
1.4
-5.58
-4.62
-3.53
10
2.41
-5.74
-11.2
EBITDA
-0.63
0.44
3
-4.46
-4.36
-4.73
-2.38
-3.51
-4.08
-13.2
EPS, basic
-0.88
-0.48
0.96
-3.27
-2.66
-2.01
5.61
1.36
-3.24
-4.43
EPS, diluted
-0.88
-0.48
0.96
-3.27
-2.66
-2.01
5.59
1.36
-3.24
-4.43
Shares, basic (weighted)
1.45
1.46
1.47
1.71
1.73
1.76
1.79
1.78
1.77
2.52
Shares, diluted (weighted)
1.45
1.46
1.5
1.71
1.73
1.76
1.79
1.78
1.77
2.52
Dividend per share
5.60
0.00
4.90
4.90
Balance sheet
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2026
Cash and equivalents
12.3
4.7
10.2
7.51
7.13
3.85
14.4
16.1
1.76
1.45
Receivables
9.88
11.9
8.76
7.56
5.86
5.25
0
0
2.24
5.79
Inventory
0.33
0.3
0.35
0.32
0.09
0.02
0.03
0
13.4
5.33
Other current assets
0.69
0.42
0.31
0.38
0.34
0.37
0.03
0.05
1.47
5.33
Total current assets
23.9
17.6
19.7
15.9
14
10.4
20.8
16.6
18.8
17.9
Property, plant and equipment
2.43
2.67
3.27
0.55
0.08
0.11
0
0.04
11.3
10.1
Lease right-of-use assets
0
0.18
0.04
0.18
0
0.01
32.9
32.7
Goodwill
0
10.7
0
Intangible assets
0.32
0
0
25.6
21.2
Other non-current assets
1.86
1.38
0.98
0.37
0.16
0
0
0.01
0.26
Total assets
28.2
21.7
24
17
14.3
10.7
21
16.7
100
84.4
Accounts payable
2.53
3.23
3.33
3.04
3.15
2.54
0.14
0.03
3.02
2.71
Accrued liabilities
0.64
0.49
0.48
Deferred revenue
0.06
0.37
0.3
0.14
0.18
0.84
2.43
Short-term debt
0
0.46
0
0
1.82
Total current liabilities
12.1
5.8
6.36
5.21
6.35
6.64
7.37
1.1
7.81
10.6
Long-term debt
0
0.59
3.57
1.03
Lease liabilities
0
0.06
0
0.11
0
0
32.4
32.5
Total liabilities
13.1
6.85
7.63
5.2
6.6
7.46
7.57
1.14
88.1
70.6
Total debt
0
1.05
0
0
38.5
20.7
Paid-in capital
15
15.4
15.4
15.9
16.2
16.3
16.5
16.2
16.2
28.9
Retained earnings
0
-0.64
0.76
-4.97
-9.59
-13.1
-3.08
-0.66
-6.4
-16.1
Other comprehensive income
0
0
-0.01
0.47
Shareholders' equity
15.1
14.8
16.3
11.1
6.67
3.19
13.4
15.5
9.84
13.3
Minority interests
0
2.05
0.48
Total equity
15.1
14.8
16.3
11.8
7.69
3.19
13.4
15.5
11.9
13.8
Total liabilities and equity
28.2
21.7
24
17
14.3
10.7
21
16.7
100
84.4
Shares outstanding
1.47
1.49
1.48
1.73
1.75
1.78
1.8
1.74
1.77
4.83
Cash flow statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2026
Net income
-1.29
-0.64
1.4
-5.58
-4.62
-3.53
10
2.41
-6.68
-13.4
Depreciation and amortization
1.45
1.35
1.17
1.65
0.48
0.06
0.06
0.01
2.64
3.63
Stock-based compensation
0.2
0.39
0.41
0.42
0.17
0.23
0.12
0.04
0.06
0.05
Deferred income tax
-0.04
0.04
0.26
-0.46
0
-3.08
-0.97
Change in receivables
-1.55
-2.06
3.29
1.16
-1.68
-0.52
0
-0.2
1.08
-0.71
Change in inventory
0.07
0.02
-0.05
0.03
-0.14
-0.07
0.01
-0.88
0.8
Change in payables
-0.89
0.7
0.1
-0.22
0.12
-0.57
0.05
-0.11
1.26
1.07
Cash from operations
-3.99
1.78
7.11
-2.31
-1.58
-3
10.7
0.52
-4.05
-3.98
Capital expenditures
-1.47
-1.16
-1.34
-0.4
-0.06
-0.11
0
-0.04
-1.17
-0.43
Acquisitions
-34.2
Purchases of investments
0
0
-0.01
Sales and maturities of investments
9.5
0
Cash from investing
8.04
-1.16
-1.3
-0.4
0.14
-0.09
-0.03
1.51
-35.1
-0.43
Debt repaid
-0.34
-1.35
-5.85
Stock issued
0.05
0
0.05
0.11
0.02
0.03
0.04
0.01
5.02
Share buybacks
-0.31
0
-0.3
0
0
-0.48
Dividends paid
0
-8.18
-0.01
-0.01
-0.01
Cash from financing
-0.31
-8.19
-0.34
0.06
1.06
-0.19
0.04
-0.47
24.9
5.33
Exchange rate effect
-0.37
Net change in cash
-2.65
-0.38
-3.28
10.7
1.55
-14.3
0.55
Free cash flow
-5.46
0.62
5.77
-2.71
-1.64
-3.11
10.7
0.48
-5.22
-4.41
Interest paid
1.63
1.88
Income taxes paid
0.24
0.74
-0.04
0.01
-0.11
0.23
0.46
0.09
0.69
0.47
Key metrics
Worked out from the statements above. Latest values use fiscal 2026. Valuation uses the share price of $3.00 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
16.4%
Gross profit / revenue.
Operating margin
-35.0%
Operating income / revenue.
EBITDA margin
-27.5%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-29.0%
Pre-tax income / revenue.
Net margin
-23.2%
Net income / revenue.
FCF margin
-9.2%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
-8.3%
Cash from operations / revenue.
Return on equity (ROE)
-84.0%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-13.2%
Net income / average total assets.
Return on invested capital (ROIC)
-40.9%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue
24.1%
Selling, general and administrative expense / revenue.
Stock-based pay / revenue
0.1%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
0.9%
Capital expenditures / revenue.
D&A / revenue
7.5%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue CAGR, 5y
22.5%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit CAGR, 5y
22.5%
Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value CAGR, 5y
14.8%
Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets CAGR, 5y
42.7%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change per year, 5y
7.8%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
1.69x
Current assets / current liabilities.
Quick ratio
0.68x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.14x
(Cash + short-term investments) / current liabilities.
Debt / equity
1.55x
Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets
24.5%
Total debt / total assets.
Liabilities / assets
83.7%
Total liabilities / total assets.
Net debt
$19.2M
Total debt - cash - short-term investments. Negative means more cash than debt.
Days inventory + days sales outstanding - days payables.
Per share
Metric
Value
How it is calculated
EPS, diluted
-$4.43
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic
-$4.43
Net income per basic share, as reported (split-adjusted).
Revenue per share
$19.09
Revenue / diluted weighted shares.
FCF per share
-$1.75
Free cash flow / diluted weighted shares.
Operating cash flow per share
-$1.58
Cash from operations / diluted weighted shares.
Book value per share
$2.76
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
0.30x
Market cap / revenue.
P/B
1.08x
Market cap / shareholders' equity. Only when equity is positive.
EV/Sales
0.70x
Enterprise value / revenue.
FCF yield
-30.8%
Free cash flow / market cap.
Earnings yield
-78.1%
Net income / market cap (the inverse of P/E).
What was BLOOMIA HOLDINGS, INC.'s revenue in fiscal 2026?
BLOOMIA HOLDINGS, INC. reported revenue of $48.1M for fiscal 2026, 27.4% higher than the year before.
Was BLOOMIA HOLDINGS, INC. profitable in fiscal 2026?
No. It reported a net loss of $11.2M.
How much free cash flow did BLOOMIA HOLDINGS, INC. generate in fiscal 2026?
Cash from operations of $4.0M minus capital expenditures of $433.0K left free cash flow of -$4.4M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.